Yabao Pharmaceutical Group Co., Ltd (600351.SS)
CNY 6.09
(0.83%)
CNY 6.09
(0.83%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 391.76 Million CNY | 25.87% |
| 2022 | 309.67 Million CNY | -7.69% |
| 2021 | 398.74 Million CNY | 23.24% |
| 2020 | 338.39 Million CNY | -38.73% |
| 2019 | 284.16 Million CNY | 0.02% |
| 2018 | 515.57 Million CNY | 19.66% |
| 2017 | 441.91 Million CNY | 107.66% |
| 2016 | 220.72 Million CNY | -49.53% |
| 2015 | 397.16 Million CNY | 18.11% |
| 2014 | 366.11 Million CNY | 30.3% |
| 2013 | 271.89 Million CNY | 3.14% |
| 2012 | 271.41 Million CNY | -29.46% |
| 2011 | 360.92 Million CNY | 57.4% |
| 2010 | 246.54 Million CNY | 8.12% |
| 2009 | 230.46 Million CNY | 25.92% |
| 2008 | 181.72 Million CNY | 40.76% |
| 2007 | 130.64 Million CNY | 57.22% |
| 2006 | 82.76 Million CNY | -5.13% |
| 2005 | 87.23 Million CNY | 8.07% |
| 2004 | 80.72 Million CNY | 29.92% |
| 2003 | 62.04 Million CNY | 31.14% |
| 2002 | 47.37 Million CNY | 20.38% |
| 2001 | 39.35 Million CNY | 41.88% |
| 2000 | 27.73 Million CNY | 77.86% |
| 1999 | 15.59 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 72.24 Million CNY | -35.97% |
| 2024 Q1 | 140.29 Million CNY | 147.99% |
| 2024 Q2 | 100.45 Million CNY | -35.5% |
| 2023 Q2 | 69.89 Million CNY | -48.16% |
| 2023 Q3 | 49.15 Million CNY | -29.68% |
| 2023 Q4 | 70.53 Million CNY | 43.51% |
| 2023 FY | - CNY | 25.87% |
| 2023 Q1 | 134.83 Million CNY | 69.41% |
| 2022 Q3 | 3.61 Million CNY | -90.78% |
| 2022 FY | - CNY | -7.69% |
| 2022 Q1 | 98.01 Million CNY | 71.84% |
| 2022 Q2 | 39.17 Million CNY | -60.03% |
| 2022 Q4 | 79.59 Million CNY | 2102.91% |
| 2021 Q3 | 62.94 Million CNY | 45.08% |
| 2021 Q2 | 43.38 Million CNY | -46.95% |
| 2021 Q1 | 81.78 Million CNY | 175.72% |
| 2021 Q4 | 57.03 Million CNY | -9.38% |
| 2021 FY | - CNY | 23.24% |
| 2020 Q1 | 57.04 Million CNY | -22.59% |
| 2020 Q2 | 34.89 Million CNY | -38.82% |
| 2020 Q3 | 46.23 Million CNY | 32.48% |
| 2020 FY | - CNY | -38.73% |
| 2020 Q4 | 29.66 Million CNY | -35.84% |
| 2019 Q2 | 103.89 Million CNY | -8.41% |
| 2019 Q1 | 113.42 Million CNY | 11.89% |
| 2019 Q4 | 73.68 Million CNY | -15.81% |
| 2019 FY | - CNY | 0.02% |
| 2019 Q3 | 87.52 Million CNY | -15.76% |
| 2018 Q3 | 94.16 Million CNY | -4.42% |
| 2018 Q4 | 101.37 Million CNY | 7.65% |
| 2018 FY | - CNY | 19.66% |
| 2018 Q1 | 85.61 Million CNY | 20.97% |
| 2018 Q2 | 98.52 Million CNY | 15.07% |
| 2017 FY | - CNY | 107.66% |
| 2017 Q4 | 70.77 Million CNY | 24.93% |
| 2017 Q3 | 56.65 Million CNY | -40.21% |
| 2017 Q1 | 53.79 Million CNY | 62.43% |
| 2017 Q2 | 94.76 Million CNY | 76.16% |
| 2016 FY | - CNY | -49.53% |
| 2016 Q1 | 89.91 Million CNY | 290.39% |
| 2016 Q4 | 33.11 Million CNY | 194.96% |
| 2016 Q2 | 40.78 Million CNY | -54.64% |
| 2016 Q3 | -34.87 Million CNY | -185.52% |
| 2015 Q3 | 101.61 Million CNY | -1.32% |
| 2015 Q1 | 92.27 Million CNY | 355.96% |
| 2015 FY | - CNY | 18.11% |
| 2015 Q4 | 23.03 Million CNY | -77.33% |
| 2015 Q2 | 102.97 Million CNY | 11.59% |
| 2014 Q1 | 83.83 Million CNY | 22.88% |
| 2014 FY | - CNY | 30.3% |
| 2014 Q4 | 20.23 Million CNY | -73.34% |
| 2014 Q3 | 75.92 Million CNY | 13.44% |
| 2014 Q2 | 66.92 Million CNY | -20.17% |
| 2013 Q3 | 30.48 Million CNY | -37.83% |
| 2013 Q4 | 68.22 Million CNY | 123.83% |
| 2013 FY | - CNY | 3.14% |
| 2013 Q1 | 58.73 Million CNY | -28.71% |
| 2013 Q2 | 49.03 Million CNY | -16.52% |
| 2012 FY | - CNY | -29.46% |
| 2012 Q4 | 82.38 Million CNY | 353.72% |
| 2012 Q3 | 18.15 Million CNY | -62.51% |
| 2012 Q1 | 41.15 Million CNY | -73.39% |
| 2012 Q2 | 48.43 Million CNY | 17.71% |
| 2011 Q2 | 27.3 Million CNY | -49.0% |
| 2011 FY | - CNY | 57.4% |
| 2011 Q4 | 154.66 Million CNY | 129.82% |
| 2011 Q1 | 53.54 Million CNY | 24.14% |
| 2011 Q3 | 67.29 Million CNY | 146.46% |
| 2010 Q2 | 61.46 Million CNY | -5.8% |
| 2010 FY | - CNY | 8.12% |
| 2010 Q4 | 43.13 Million CNY | 27.82% |
| 2010 Q3 | 33.74 Million CNY | -45.1% |
| 2010 Q1 | 65.25 Million CNY | 100.39% |
| 2009 Q3 | 54.87 Million CNY | -5.35% |
| 2009 FY | - CNY | 25.92% |
| 2009 Q4 | 32.56 Million CNY | -40.66% |
| 2009 Q2 | 57.98 Million CNY | 35.75% |
| 2009 Q1 | 42.71 Million CNY | 21.21% |
| 2008 Q2 | 35.44 Million CNY | -4.23% |
| 2008 FY | - CNY | 40.76% |
| 2008 Q4 | 35.23 Million CNY | 5.19% |
| 2008 Q3 | 33.49 Million CNY | -5.49% |
| 2008 Q1 | 37.01 Million CNY | 192.6% |
| 2007 Q1 | 23.83 Million CNY | -1.85% |
| 2007 Q2 | 24.32 Million CNY | 2.03% |
| 2007 Q3 | 27.82 Million CNY | 14.41% |
| 2007 Q4 | 12.64 Million CNY | -54.54% |
| 2007 FY | - CNY | 57.22% |
| 2006 Q2 | 14.73 Million CNY | -21.79% |
| 2006 Q4 | 24.28 Million CNY | -13.0% |
| 2006 FY | - CNY | -5.13% |
| 2006 Q1 | 18.83 Million CNY | -40.75% |
| 2006 Q3 | 27.91 Million CNY | 89.51% |
| 2005 Q2 | 16.66 Million CNY | -18.42% |
| 2005 Q1 | 20.43 Million CNY | -14.09% |
| 2005 Q3 | 20.95 Million CNY | 25.71% |
| 2005 Q4 | 31.79 Million CNY | 51.7% |
| 2005 FY | - CNY | 8.07% |
| 2004 Q4 | 23.78 Million CNY | 8.5% |
| 2004 Q2 | 15.7 Million CNY | -12.47% |
| 2004 FY | - CNY | 29.92% |
| 2004 Q1 | 17.93 Million CNY | 20.57% |
| 2004 Q3 | 21.92 Million CNY | 39.62% |
| 2003 Q2 | 16.83 Million CNY | 16.2% |
| 2003 Q1 | 14.48 Million CNY | 63.87% |
| 2003 FY | - CNY | 31.14% |
| 2003 Q4 | 14.87 Million CNY | -8.94% |
| 2003 Q3 | 16.33 Million CNY | -2.92% |
| 2002 Q4 | 8.83 Million CNY | -8.65% |
| 2002 Q3 | 9.67 Million CNY | -17.62% |
| 2002 Q2 | 11.74 Million CNY | 9.79% |
| 2002 FY | - CNY | 20.38% |
| 2002 Q1 | 10.69 Million CNY | 0.0% |
| 2001 FY | - CNY | 41.88% |
| 2000 FY | - CNY | 77.86% |
| 1999 FY | - CNY | 0.0% |